Valmark Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Sell
5,637
-26
-0.5% -$2.1K ﹤0.01% 528
2026
Q1
$491K Buy
5,663
+965
+21% +$92.4K 0.01% 470
2025
Q4
$451K Sell
4,698
-1,706
-27% -$166K 0.01% 464
2025
Q3
$610K Sell
6,404
-134
-2% -$12.3K 0.01% 403
2025
Q2
$570K Sell
6,538
-58
-0.9% -$4.92K 0.01% 424
2025
Q1
$593K Sell
6,596
-1,573
-19% -$141K 0.01% 394
2024
Q4
$653K Sell
8,169
-1,228
-13% -$106K 0.01% 380
2024
Q3
$846K Sell
9,397
-77
-0.8% -$6.48K 0.01% 332
2024
Q2
$746K Buy
9,474
+718
+8% +$58.9K 0.01% 329
2024
Q1
$763K Sell
8,756
-26
-0.3% -$2.22K 0.01% 311
2023
Q4
$723K Sell
8,782
-833
-9% -$63.5K 0.01% 301
2023
Q3
$753K Buy
9,615
+461
+5% +$38.6K 0.02% 266
2023
Q2
$806K Sell
9,154
-413
-4% -$35.6K 0.02% 257
2023
Q1
$771K Sell
9,567
-461
-5% -$37.6K 0.02% 251
2022
Q4
$779K Buy
10,028
+114
+1% +$9.24K 0.02% 241
2022
Q3
$801K Sell
9,914
-82
-0.8% -$7.37K 0.02% 213
2022
Q2
$897K Sell
9,996
-302
-3% -$30.6K 0.02% 204
2022
Q1
$1.14M Buy
10,298
+187
+2% +$19.8K 0.02% 190
2021
Q4
$1.05M Sell
10,111
-8
-0.1% -$926 0.02% 190
2021
Q3
$1.27M Buy
10,119
+45
+0.4% +$5.82K 0.02% 157
2021
Q2
$1.25M Buy
10,074
+596
+6% +$74.8K 0.02% 160
2021
Q1
$1.12M Buy
9,478
+608
+7% +$71.3K 0.02% 170
2020
Q4
$1.04M Buy
+8,870
New +$976K 0.02% 163

Other funds holding MDT

Valmark Advisers's MDT Position: Q2 2026 in Review

Valmark Advisers reduced its Medtronic (MDT) stake by 0.46% in Q2 2026, selling an estimated $2.1K and leaving 5,637 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Valmark Advisers first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.27M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Valmark Advisers held 5,637 shares of Medtronic worth $441K as of Q2 2026.
  • Valmark Advisers sold 26 Medtronic shares in Q2 2026, an estimated $2.1K.
  • Medtronic made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #528 holding.
  • Valmark Advisers first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
  • Valmark Advisers's Medtronic position peaked at $1.27M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.